2 Cannabis Stocks That Could Easily Double in the Next 5 Years

Cannabis stocks such as Green Thumb and Cresco Labs are well poised to deliver outsized gains to long-term investors.

| More on:
edit Jars of marijuana

Image source: Getty Images

For investors who aim to generate market-beating returns, companies that are part of the cannabis sector remain an attractive bet. While domestic marijuana producers such as HEXO, Aurora Cannabis, and Cronos are grappling with high cash burn as well as mounting losses, their counterparts south of the border are racing towards profitability.

We’ll look at two U.S.-based cannabis stocks that should be part of your growth portfolio right now, as they are well poised to double your investment in the next five years.

Green Thumb Industries

Valued at a market cap of $6.65 billion, Green Thumb Industries (CNSX:GTII) has managed to increase its sales from US$62.5 million in 2018 to US$556 million in 2020. This allowed it to report an operating profit of US$106 million last year compared to a loss of US$23.8 million in 2018. This solid growth in revenue and improvement in profit margins has allowed GTII stock to return 245% to investors in the last five years.

Green Thumb is a multi-state operator and recently opened its 65th retail location in the United States. It has a wide portfolio of cannabis products that are manufactured and shipped from 16 facilities. The recent wave of cannabis legalization in the U.S. has allowed Green Thumb to enter new markets and gain traction in these regions via acquisitions as well. The states of New York and New Jersey legalized recreational marijuana use in 2021, but sales will begin next year.

In the second quarter of 2021, Green Thumb sales rose by 85.4% year over year to US$222 million. It was the company’s fourth consecutive quarter of net income that stood at US$22.1 million, indicating a margin of 10%. The June quarter was also the sixth consecutive quarter where Green Thumb reported a positive operating cash flow.

A positive cash flow is extremely important, as it reduces the need to raise growth capital that dilutes shareholder wealth while allowing companies to grow inorganically. Green Thumb closed three acquisitions in 2021 and is nearing a revenue run rate of US$1 billion each year.

Analysts tracking the stock expect sales to touch US$900 million in 2021 and US$1.2 billion in 2022.

Cresco Labs

Another cannabis stock that can outpace the broader markets and deliver inflation-crushing returns is Cresco Labs (CNSX:CL). A marijuana giant with a presence in 10 states, Cresco Labs has 47 retail licences and owns 20 production facilities.

The company’s revenue more than doubled in the second quarter of 2021 to US$210 million. Its adjusted EBITDA stood at US$45.5 million while GAAP earnings were US$2.7 million. Cresco claimed it’s on track to generate US$1 billion in total sales this year, allowing gross margins to exceed 50% in the second half of 2021.

Cresco has historically entered markets where licences are limited, which reduces competition. This allows the company to build brand recognition and increase customer loyalty over time.

Analysts tracking the stock expect sales to increase by 126.5% to US$1.08 billion in 2021 and by 39.5% to US$1.5 billion in 2022. Its adjusted bottom line is forecast to improve from a loss of US$0.24 per share in 2020 to earnings of US$0.38 in 2022.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Cresco Labs Inc. and Green Thumb Industries.

More on Cannabis Stocks

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.
Cannabis Stocks

Canopy Growth: Is There Budding Potential in the Cannabis Market?

Canopy Growth stock hit 52-week lows recently on news of needing to re-file on its BIoSteel business, so what now?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

What’s Happening With Cannabis Stocks in May 2023?

Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is…

Read more »

Cannabis smoke
Cannabis Stocks

Are Cannabis Stocks a Good Buy in May 2023?

If you're going to buy cannabis stocks, these are pretty much the only two I would consider. Even so, you…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Aurora Cannabis: Time to Light Up Your Portfolio?

Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth…

Read more »

Target. Stand out from the crowd
Tech Stocks

These Undervalued TSX Stocks Are a Bargain in May 2023

If you're willing to bet on a rebound, these are the three TSX stocks I would consider first as they…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Stock Is Scraping 52-Week Lows: Will it Bottom Out Soon?

Tilray (TSX:TLRY) stock remains down 53% in the last year, but when will this company hit the bottom and start…

Read more »

Medicinal research is conducted on cannabis.
Metals and Mining Stocks

2 Canadian Stocks That Are Simply Too Cheap to Avoid

These two Canadian stocks have sunk lower and lower, which is why now could be the right time for long-term…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

1 Marijuana Stock I’d Buy Over Aurora Cannabis

Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio.

Read more »